Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, Fukawa T, Nakatsuji H, Bando Y, Uehara H, Fukumori T, Takahashi M, Kanayama HO.
Kusuhara Y, et al.
Anticancer Res. 2019 Feb;39(2):703-711. doi: 10.21873/anticanres.13166.
Anticancer Res. 2019.
PMID: 30711948